[go: up one dir, main page]

JPS5793913A - Enhancing agent for spermous vital power - Google Patents

Enhancing agent for spermous vital power

Info

Publication number
JPS5793913A
JPS5793913A JP55170562A JP17056280A JPS5793913A JP S5793913 A JPS5793913 A JP S5793913A JP 55170562 A JP55170562 A JP 55170562A JP 17056280 A JP17056280 A JP 17056280A JP S5793913 A JPS5793913 A JP S5793913A
Authority
JP
Japan
Prior art keywords
vitamin
agent
arginine
spermous
enhancing agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP55170562A
Other languages
Japanese (ja)
Other versions
JPS6345370B2 (en
Inventor
Tadao Hasegawa
Takao Suzuki
Yuji Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP55170562A priority Critical patent/JPS5793913A/en
Publication of JPS5793913A publication Critical patent/JPS5793913A/en
Publication of JPS6345370B2 publication Critical patent/JPS6345370B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: An enhancing agent for spermous vital power, containing arginine and vitamin E as active constituents in a daily dose thereof in a specific range, and usable as a remedy and preventing agent for the male sterility.
CONSTITUTION: A composition containing arginine and vitamin E in a daily dose per 1kg body weight of 5W300mg arginine and 0.2W20mg vitamin E. The agent may be such that the arginine and vitamin E are administered separately or in different dosage forms, e.g. either one administered orally and the other injected intravenously. The resultant composition is capable of increasing the number of spermatozoa of a male adult and mobility thereof; therefore, the agent is useful as a preventing agent and remedy for the male sterility.
COPYRIGHT: (C)1982,JPO&Japio
JP55170562A 1980-12-03 1980-12-03 Enhancing agent for spermous vital power Granted JPS5793913A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP55170562A JPS5793913A (en) 1980-12-03 1980-12-03 Enhancing agent for spermous vital power

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55170562A JPS5793913A (en) 1980-12-03 1980-12-03 Enhancing agent for spermous vital power

Publications (2)

Publication Number Publication Date
JPS5793913A true JPS5793913A (en) 1982-06-11
JPS6345370B2 JPS6345370B2 (en) 1988-09-09

Family

ID=15907143

Family Applications (1)

Application Number Title Priority Date Filing Date
JP55170562A Granted JPS5793913A (en) 1980-12-03 1980-12-03 Enhancing agent for spermous vital power

Country Status (1)

Country Link
JP (1) JPS5793913A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0755633A1 (en) * 1995-07-28 1997-01-29 Herbert Schlachter Two phases preparation
US6646006B2 (en) 1993-06-11 2003-11-11 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US7045151B2 (en) 2000-12-22 2006-05-16 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
WO2008052432A1 (en) * 2006-10-27 2008-05-08 Shengxian Huang A medicament for improving the semen quality and treating male infertility
US7557087B2 (en) 2004-03-01 2009-07-07 Lumen Therapeutics, Llc Compositions and methods for treating diseases

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6646006B2 (en) 1993-06-11 2003-11-11 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
US7452916B2 (en) 1993-06-11 2008-11-18 The Board Of Trustees Of The Leland Stanford Junior University Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
EP0755633A1 (en) * 1995-07-28 1997-01-29 Herbert Schlachter Two phases preparation
WO1997004668A3 (en) * 1995-07-28 1997-06-12 Herbert Schlachter Two-stage preparation
US6471969B1 (en) 1995-07-28 2002-10-29 Herbert Schlachter Two-phase preparation
US6989164B2 (en) 2000-12-22 2006-01-24 The Daily Wellness Company Method and composition for improving male fertility health
US7045151B2 (en) 2000-12-22 2006-05-16 The Daily Wellness Company Method and composition for improving fertility health in female and male animals and humans
US7557087B2 (en) 2004-03-01 2009-07-07 Lumen Therapeutics, Llc Compositions and methods for treating diseases
WO2008052432A1 (en) * 2006-10-27 2008-05-08 Shengxian Huang A medicament for improving the semen quality and treating male infertility

Also Published As

Publication number Publication date
JPS6345370B2 (en) 1988-09-09

Similar Documents

Publication Publication Date Title
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
MY101791A (en) New benzimidazole derivatives
EP0165352A3 (en) Clear micellized solutions of fat soluble essential nutrients
ATE189400T1 (en) BONE GROWTH-PROMOTING COMPOSITION
GR76810B (en)
ES2001706A6 (en) PROCEDURE FOR THE PREPARATION OF PEPTIDIC DERIVATIVES
HU9400430D0 (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
DeFuria et al. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report
JPS56104815A (en) Remedy for peripheral orthostatic hypotension
KR910005858A (en) Fatty acid therapy
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
JPS5793913A (en) Enhancing agent for spermous vital power
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
KR920702225A (en) Pharmaceutical composition
JPS5781409A (en) External plaster
JPS57109721A (en) Carcinostatic agent
KR930003913A (en) Methods and pharmaceutical compositions for enhancing the antitussive effect of dextromethorphan
MY101916A (en) Etoposide oral dosage form.
JPS6456622A (en) Percutaneous absorbefacient base composition
Venkatesan et al. Study on drug interactions
JPS5326316A (en) Drug containing active vitamin d3 derivatives and its preparation
MA21895A1 (en) ASSOCIATION OF VITAMIN "A" WITH PHYSIOLOGICAL DOSE AND DIFFERENT ACTIVE INGREDIENTS.
JPS5498339A (en) Carcinostatic agent
JPS567720A (en) Antiphlogistic agent